Is MAVENCLAD a chemo drug?

Official Answer. No, Mavenclad is not a chemotherapy (cancer) drug. It is an oral purine antimetabolite approved for the treatment of relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease, in adults.

What kind of drug is cladribine?

Cladribine is used to treat hairy cell leukemia (cancer of a certain type of white blood cell). Cladribine is in a class of medications known as purine analogs. It works by stopping or slowing the growth of cancer cells.

Is cladribine a chemotherapy?

Cladribine is a chemotherapy drug used mainly to treat hairy cell leukaemia and occasionally other types of leukaemia.

Who created MAVENCLAD?

Merck, a leading science and technology company, today announced that the U.S. Food and Drug Administration (FDA) has approved MAVENCLAD® (cladribine) tablets for the treatment of adults with relapsing-remitting disease (RRMS) and active secondary progressive disease (SPMS).

Is MAVENCLAD an immunosuppressant?

MAVENCLAD®, also known as cladribine, is an oral selective Immunosuppressant. It is indicated as monotherapy for the treatment of adult patients with relapsing-remitting multiple sclerosis (RRMS) to reduce the frequency of clinical exacerbations and delay the progression of disability.

Does MAVENCLAD reset your immune system?

Mavenclad Reduces MS Relapses by Resetting the Immune System Data showed that the drug lowers both immune B-cells and, to a lesser degree, T-cells.

Is cladribine an immunosuppressant?

As a selective immune reconstitution therapy (SIRT), cladribine acts as a short-term immunosuppressant, relative to other maintenance immunosuppressive therapies that result in long-term immunosuppression.

Is cladribine a biologic?

Cladribine (2-chlorodeoxyadenosine [2-CdA]) is a synthetic chlorinated deoxyadenosine analog that is biologically active in selected cell types and provides targeted and sustained reduction of circulating T and B lymphocytes implicated in the pathogenesis of MS.

What are the side effects of cladribine?

Cladribine can commonly cause a mild rash that is usually not serious….Common side effects may include:

fever;
nausea, vomiting, diarrhea;
headache, tiredness;
rash;
cough; or.
pain, bruising, swelling, or irritation where the medicine was injected.

Can hairy cell leukemia be cured?

If you experience signs and symptoms of the cancer, you may decide to undergo treatment. The majority of people with hairy cell leukemia eventually need treatment. There is no cure for hairy cell leukemia. But treatments are effective at putting hairy cell leukemia in remission for years.

What is the cost of MAVENCLAD?

The current annual list price for MAVENCLAD ranges from $65,090 to $162,725 (based on 8 to 20 tablets per patient per year, depending on patient weight). But many patients will not have to pay this amount. That’s because the amount you pay depends on your insurance plan and if you are eligible for financial support.

How long is your immune system compromised after MAVENCLAD?

For most patients, the active ingredient in MAVENCLAD does not remain in the body beyond 1 week. The number of T and B cells reach their lowest level about 2-3 months after the start of each treatment course and were lower with each additional treatment course.

Is MAVENCLAD a chemo drug?